Cannabis Freedom Index
← History

Medical 🇫🇷 France

France begins a medical cannabis experiment

A trial for up to 3,000 patients with conditions such as severe epilepsy and cancer pain began, the first legal medical use in France. It has been extended several times without becoming permanent.[1][2]

Index score

1314

+1 point

The story · written by opus-5.5,

France first allowed cannabis as a medicine in the form of an experiment. The trial began in March 2021. More than five years later it has ended without a permanent system to replace it, and the patients who were in it remain in a transition period that has been extended.

The experiment rests on Article 43 of the social security financing law for 2020, Law 2019-1446 of 24 December 2019, which authorised it for three years. A decree of 7 October 2020 and an order of 16 October 2020 set the rules and the specifications of the products.

Who could be treated

Condition
Neuropathic pain that resists other treatments
Some forms of drug-resistant epilepsy
Some resistant symptoms of cancer or its treatment
Palliative care
Painful spasticity in multiple sclerosis or other diseases of the central nervous system

How it worked

  • The first prescription came from a doctor at one of the structures selected for the trial. Later a doctor chosen by the patient could take over, if trained.
  • The medicine was dispensed by the unit’s pharmacy or by a town pharmacy that had agreed and trained its staff.
  • A prescription covered 28 days at most.
  • Two forms were allowed, both containing THC and CBD: dried flower for inhalation, and oral forms such as oil.
  • Smoking was excluded from the protocol.
  • The medicines were paid for by the health insurance system.

How it ended

DateEvent
March 2021first patients enrolled
27 March 2024no new patients admitted
31 December 2024the experiment ends
31 March 2026first end date of the transition period
after thatthe transition is extended until three months after an opinion from the health authority that had not yet been published

Patients already included keep their prescriptions during the transition. No date has been set for a general system. A decree on reimbursement followed in 2026.

Why the index moved

The index moved France from 13 to 14 with the 2021 experiment. Only access changed, from 0 to 1: a lawful supply existed for the first time, for a capped group of patients with five conditions. Nothing changed for anyone else, and use outside the trial stayed a criminal offence.[1]

Score by segment 0 to 10

  1. Possession · 25%1 1
  2. Personal cultivation · 25%1 1
  3. Punishment & enforcement · 20%3 3
  4. Sharing & gifting · 10%1 1
  5. Consumption · 10%1 1
  6. Legal access · 10%0 1+1

The bar shows the score after the change; the tick marks where it stood before. The scores after the change are France's current scores.

References

  1. Service-Public.fr — Therapeutic cannabisarchived
  2. Wikipedia — Cannabis in Francearchived

Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.

    ↑↓ to move, ↵ to open.